Zoetis

ZTS66

S&P500

$176.96arrow_drop_up0.14%$0.25

S&P500

ZTS66

$176.96

arrow_drop_up0.14%$0.25

S&P500

Performance History

Key Stats
Open	$176.35
Prev. Close	$176.71
EPS	5.32

Next Earnings Date	Mar 3, 2025

	LOW	HIGH
Day Range	176.28	178.21
52 Week Range	144.80	201.92

Ratios







EPS	5.32

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Zoetis (ZTS)

Zoetis Inc (ZTS) is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines. With a rich history in the animal health industry, Zoetis has established itself as a trusted name in providing innovative solutions to improve the health and well-being of animals worldwide. The company's portfolio includes a wide range of products for livestock, poultry, and companion animals, addressing a diverse set of medical needs.

Zoetis Inc (ZTS) has a strong market presence, with a market capitalization of over $70 billion. This underscores the company's position as a key player in the animal health sector. The company's stock price history reflects its consistent growth and performance over the years, demonstrating its ability to generate value for investors. ZTS stock has shown resilience even in challenging market conditions, which speaks to the strength of the company's business model and its ability to adapt to changing dynamics.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Ms. Kristin C. Peck
Headquarters: Parsippany
Employees: 13800
Exchange: NYSE

Keep an eye on Zoetis

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Zoetis 's (ZTS) price per share?

The current price per share for Zoetis (ZTS) is $176.96. The stock has seen a price change of $0.25 recently, indicating a 0.14% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Zoetis (ZTS)?

For Zoetis (ZTS), the 52-week high is $201.92, which is 14.1% from the current price. The 52-week low is $144.8, the current price is 22.21% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Zoetis (ZTS) a growth stock?

Zoetis (ZTS) has shown an average price growth of -4.13% over the past three years. It has received a score of 39 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Zoetis as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Zoetis (ZTS) stock price performance year to date (YTD)?

As of the latest data, Zoetis (ZTS) has a year-to-date price change of -9.98%. Over the past month, the stock has experienced a price change of -6.62%. Over the last three months, the change has been -2.86%. Over the past six months, the figure is 2.85%. Looking at a longer horizon, the five-year price change stands at 47.7%.

help

Is Zoetis (ZTS) a profitable company?

Zoetis (ZTS) has a net income of $2.34B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.28% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 38.53% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $8.54B, with a revenue growth rate of 5.74%, providing insight into the company's sales performance and growth. The gross profit is $5.83B. Operating income is noted at $3.07B. Furthermore, the EBITDA is $3.94B.

help

What is the market capitalization of Zoetis (ZTS)?

Zoetis (ZTS) has a market capitalization of $79.84B. The average daily trading volume is 177.07, indicating the stock's liquidity and investor engagement.

News

ANIMAL GROWTH PROMOTERS

Technological Advancements in Phytogenic Additives Aiming towards Robust Growth of the Animal Growth Promoter Market | Future Market Insights, Inc.

Corcept Moves 6.5% Higher: Will This Strength Last?

SUSTAINABLE AGRICULTURE

ORGANIC FARMING

AGROFORESTRY

PRECISION AGRICULTURE

TNR, The Niche Research: Global Sustainable Agriculture Market By Type, By Application, By End User, By Region is projected to Grow at a CAGR of 11.4% during the forecast period (2024 – 2034)

Poultry Vaccines Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Report 2024

Veterinary Vaccines Market is Poised to Grow at CAGR of 6.2% by 2031 | SkyQuest